2.82 USD
↗ 0.03 (1.18%)PRE MARKET (AS OF 05:02 AM EDT)
Atossa Therapeutics, Inc. Common Stock
ATOSNASDAQ • USD
Market: OPEN
ATOS is currently priced at $2.82. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 17, 2026.
Open?$2.80
High?$2.82
Low?$2.80
Prev. Close?$2.79
Volume?24
Avg. Volume?87.7K
VWAP?$2.80
Rel. Volume?0.00x
Bid / Ask
Bid?$2.38 × 100
Ask?$3.19 × 100
Spread?$0.81
Midpoint?$2.79
Valuation & Ratios
Market Cap?27.8M
Shares Out?10.0M
Float?7.7M
Float %?89.2%
P/E Ratio?N/A
P/B Ratio?1.04
EPS?-$3.78
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Themes
Employees
14
Market Cap
25.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-11-08
Address
1448 NW MARKET STREET
SEATTLE, WA 98107
Phone: 206.588.0256
SEATTLE, WA 98107
Phone: 206.588.0256
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.48Distress
Confidence?54%Low
Short InterestVery High
Short % of Float?9.90%Elevated
Short Interest?760.1K
Days to Cover?13.5
Free Float7.7M
Avg Daily Volume56.4K
Settlement Date2026-07-31
Financial Health
Current Ratio?5.69Strong
Quick Ratio?5.14Strong
Cash Ratio?4.79Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.04CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-140.6%WEAK▾
S&P3
ROA?-116.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-35783000
Enterprise Value?$1.7M
Fundamentals ratios updated end of day